UBS Group »

Fate Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 444k 7.34
2023-12-31 $659k 176k 3.74
2023-09-30 $141k 67k 2.12
2023-06-30 $1.2M 260k 4.76
2023-03-31 $2.4M 418k 5.70
2022-12-31 $2.9M 292k 10.09
2022-09-30 $53k 2.4k 22.41
2022-06-30 $1.3M 53k 24.78
2022-03-31 $5.4M 140k 38.94
2021-12-31 $7.4M 128k 58.18
2021-09-30 $1.6M 27k 59.63
2021-06-30 $1.4M 16k 86.73
2021-03-31 $3.7M 45k 82.45
2020-12-31 $8.0M 88k 90.97
2020-09-30 $277k 6.9k 39.98
2020-06-30 $179k 5.2k 34.29
2020-03-31 $157k 7.0k 22.23
2019-12-31 $995k 52k 19.23
2019-09-30 $2.7M 172k 15.53
2019-06-30 $769k 38k 20.00
2019-03-31 $167k 9.6k 17.50
2018-12-31 $1.2M 88k 13.08
2018-09-30 $505k 30k 16.67
2018-06-30 $1.1M 101k 11.34
2018-03-31 $89k 9.2k 9.74
2017-12-31 $38k 6.0k 6.25
2017-09-30 $7.0k 1.8k 4.00
2017-06-30 $141k 44k 3.23
2016-12-31 $2.0k 738 2.71
2016-09-30 $7.0k 2.3k 3.08
2016-03-31 $4.0k 2.1k 1.88
2015-12-31 $14k 4.2k 3.31
2015-09-30 $20k 3.8k 5.27
2015-03-31 $17k 3.4k 4.94